EXPLORE!

FDA Approves Lumisight for Breast Cancer Surgery

  424 Views

Emedinexus    08 June 2025

The FDA has approved Lumisight (pegulicianine) for use in breast cancer lumpectomies to help detect residual cancerous tissue. Given via IV before surgery, this fluorescent imaging drug enables surgeons to better identify and remove remaining cancer cells, potentially reducing the need for follow-up procedures.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.